Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: The role of antibodies in neuromuscular junction disorders is well established with antibodies to acetylcholine receptor, muscle-specific kinase, and voltage-gated calcium channels. The diseases associated with these antibodies, myasthenia gravis and the Lambert-Eaton myasthenic syndrome, respond well to symptomatic treatments (e.g., cholinesterase inhibitors) and to immunotherapies such as plasma exchange, intravenous immunoglobulin, oral steroids, and steroid-sparing drugs. The role of the antibodies has been established by a variety of in vitro and in vivo approaches. More recently, antibodies to voltage-gated potassium channels have been identified in patients with autoimmune forms of acquired neuromyotonia. Over the last decade, antibodies to CNS membrane receptors or ion channels have begun to be identified and these antibodies define antibody-mediated CNS diseases that also respond to immunotherapies. SUMMARY: The paradigms gained from the study of the peripheral conditions has led to a better appreciation of the role of antibodies in neurological disorders and a growing recognition of their role in central nervous system (CNS) diseases.

Original publication




Journal article


J Clin Immunol

Publication Date



30 Suppl 1


S97 - 102


Adrenal Cortex Hormones, Adult, Aquaporin 4, Autoantibodies, Autoantigens, Autoimmune Diseases of the Nervous System, Calcium Channels, Channelopathies, Glutamate Decarboxylase, Humans, Immunoglobulins, Intravenous, Immunotherapy, Infant, Newborn, Myasthenic Syndromes, Congenital, Paraneoplastic Syndromes, Nervous System, Plasma Exchange, Potassium Channels, Voltage-Gated, Receptors, Neurotransmitter